Skull-Implanted device aims to lift severe depression

NCT ID NCT07594483

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early study tests a new device called the Motif XCS System for people with severe depression that hasn't improved with multiple medications. The device is implanted in the skull and stimulates a key brain area without piercing the brain's protective covering. The main goal is to check safety, but researchers will also track mood changes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Motif XCS System (implanted brain stimulation device)

What this could lead to

If it works, this could offer a new treatment option for people with severe depression that hasn't improved with medication.

What could go wrong

This is a very early, small trial (20 people) focused on safety, so it may not show clear benefit. The device requires surgery to implant, which carries risks like infection or side effects from brain stimulation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression Depressive Disorder, Treatment-Resistant major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••